Complete the following sentences by choosing from the list of options. The nurse is planning education for a client prescribed nitroglycerin sublingual tablets. The nurse should instruct the client to

dropdown

due to the risk for

dropdown

.

A. Productive cough: A persistent cough is commonly associated with ACE inhibitors, not angiotensin receptor blockers like valsartan. Clients taking valsartan rarely experience cough as a side effect.

B. Hypotension: Valsartan lowers blood pressure by blocking angiotensin II receptors, which can sometimes lead to excessive blood pressure reduction. Monitoring for hypotension, especially after the initial doses or in clients with volume depletion, is important to prevent dizziness, falls, or syncope.

C. Respiratory depression: Respiratory depression is not a known adverse effect of valsartan. The medication primarily affects the cardiovascular system without depressing the respiratory drive.

D. Hypokalemia: Unlike some diuretics, valsartan does not typically cause potassium loss. In fact, ARBs may slightly increase serum potassium levels, so hypokalemia is not a common concern with this drug.

A. The client reports a recent onset of muscle pain: Muscle pain or weakness (myalgia) is a known adverse effect of atorvastatin and can indicate a serious complication such as rhabdomyolysis. This finding requires immediate assessment and possible adjustment of the medication regimen.

B. The client's high-density lipoprotein (HDL) increased: An increase in HDL is a desired effect of atorvastatin therapy. This finding is beneficial and indicates that the medication is helping improve lipid profile and cardiovascular risk.

C. The client started taking oral contraceptive pills: While statins can slightly increase the hormone levels of birth control pills, this is a known interaction but not an immediate clinical "finding" that would be as concerning as potential muscle breakdown.

D. The client's blood pressure is 116/78 while sitting: This blood pressure reading is within normal limits for an adult. It does not indicate a concerning clinical finding in the context of atorvastatin therapy.